The University of Manchester in the UK has unveiled a new genetic test for the accurate prediction of breast cancer risk in women who have a family history of the cancer and test negative for BRCA1/2 gene mutations.
Developed by researchers at the university in alliance with those from Manchester University NHS Foundation Trust (MFT), the test evaluates the risk based on genetic variations in the DNA of an individual.